Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on the table. #longevity# #RonaTherapeutics# #Roche# #ALK7# #biotech#

ABC News' Reena Roy sits down with one young woman who survived a very aggressive form of breast cancer and is now using her story to help others. The diagnosis brought her together with a cousin, who she never knew.

$ONDS and $PLTR announced Regna AI, a new company developing specialized AI models for governments and businesses that want to retain control over their models and data. Initially wholly owned by Ondas, Regna will use Palantir’s AI platform and model-training infrastructure. Ondas will also be its first customer. The initial focus is intelligence and surveillance, with models designed to run on drones, ground vehicles and other hardware even with limited connectivity. Initial customer deployments are planned over the coming months.